Exact Sciences (EXAS) in Focus: Stock Up 5.2% – Tale of the Tape

ZacksExact Sciences Corporation (EXAS) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the trend for the healthcare company since Feb 6, as the stock is now up over 19%.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Exact Sciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Emergent BioSolutions, Inc. (EBS) and Biogen Idec Inc. (BIIB). While Emergent BioSolutions and Biogen sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply